New Study Confirms the Long-Term Benefits of the Impella CP Heart Pump in Cardiogenic Shock Patients Recent findings confirm that the Impella CP heart pump offers significant long-term survival benefits for patients with cardiogenic shock, as published in a leading medical journal.

New Study Confirms the Long-Term Benefits of the Impella CP Heart Pump in Cardiogenic Shock Patients #United_States #New_York #Johnson_&_Johnson #Impella_CP #cardiogenic_shock

New Study Highlights Lower Hemolysis Levels of SHA Whisper Device Compared to Impella CP A recent study reveals that the SHA Whisper device causes significantly less hemolysis compared to the Impella CP, indicating a promising advancement in circulatory support technology.

New Study Highlights Lower Hemolysis Levels of SHA Whisper Device Compared to Impella CP #USA #Salt_Lake_City #SHA_Whisper #Impella_CP #Heart_Assist